Hisako Akiyama

Wako, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Cerebrospinal fluid sphingolipid and sterol metabolite profiles of neurologically normal subjects.

Cerebrospinal fluid sphingolipid and sterol metabolite profiles of neurologically normal subjects.

Journal: Molecular and cellular biochemistry

Published: February 14, 2025

A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy.

A lipid nanoparticle-based oligodendrocyte-specific mRNA therapy.

Journal: Molecular therapy. Nucleic acids

Published: April 12, 2024

Ligand-Controlled Stereoselective Synthesis and Biological Activity of 2-Exomethylene Pseudo-glycoconjugates: Discovery of Mincle-Selective Ligands.

Ligand-Controlled Stereoselective Synthesis and Biological Activity of 2-Exomethylene Pseudo-glycoconjugates: Discovery of Mincle-Selective Ligands.

Journal: Angewandte Chemie (International ed. in English)

Published: February 20, 2023

A pilot study assessing sphingolipids and glycolipids dysmetabolism in idiopathic normal pressure hydrocephalus.

A pilot study assessing sphingolipids and glycolipids dysmetabolism in idiopathic normal pressure hydrocephalus.

Journal: Biochemical and biophysical research communications

Published: November 21, 2022

Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes).

Impact of Gba2 on neuronopathic Gaucher's disease and α-synuclein accumulation in medaka (Oryzias latipes).

Journal: Molecular brain

Published: February 14, 2021

Corrigendum to "Galabiosylceramide is present in human cerebrospinal fluid".

Corrigendum to "Galabiosylceramide is present in human cerebrospinal fluid".

Journal: Biochemical and biophysical research communications

Published: February 02, 2021

Galabiosylceramide is present in human cerebrospinal fluid.

Galabiosylceramide is present in human cerebrospinal fluid.

Journal: Biochemical and biophysical research communications

Published: November 24, 2020

Cerebrospinal Fluid Profiles in Parkinson's Disease: No Accumulation of Glucosylceramide, but Significant Downregulation of Active Complement C5 Fragment.

Cerebrospinal Fluid Profiles in Parkinson's Disease: No Accumulation of Glucosylceramide, but Significant Downregulation of Active Complement C5 Fragment.

Journal: Journal of Parkinson's disease

Published: November 20, 2020

Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.

Glucocerebrosidases catalyze a transgalactosylation reaction that yields a newly-identified brain sterol metabolite, galactosylated cholesterol.

Journal: The Journal of biological chemistry

Published: December 31, 2019

Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish.

Role of β-glucosidase 2 in aberrant glycosphingolipid metabolism: model of glucocerebrosidase deficiency in zebrafish.

Journal: Journal of lipid research

Published: May 27, 2019

GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease.

GBA haploinsufficiency accelerates alpha-synuclein pathology with altered lipid metabolism in a prodromal model of Parkinson's disease.

Journal: Human molecular genetics

Published: September 13, 2018

A novel function for glucocerebrosidase as a regulator of sterylglucoside metabolism.

A novel function for glucocerebrosidase as a regulator of sterylglucoside metabolism.

Journal: Biochimica et biophysica acta. General subjects

Published: April 24, 2017

Showing 1-12 of 17

Last Updated: 09/26/2026